Shareholdings in Emotra AB (including related persons): 405,507 shares.
Claes Holmberg has a master’s degree in engineering and received his PhD in theoretical physics in 1986. Former Executive VP of Nobel Biocare, 1986–95 and CEO of Mediteam AB/Biolin AB, 1996–2003 and Biolight AB, 2003–2011. Former member and/or chairman of the board of several medical device companies and national interdisciplinary research programmes.
Shareholdings in Emotra AB: 43,988 shares
Daniel Poté has a solid background in international marketing of medical devices. He has previously worked with marketing on a manager level at Nobel Biocare, Haemochrom Diagnostica GmbH and other companies. Mr Poté joined Vitrolife AB in 2009. His area of responsibility there has consistently concerned international marketing activities. In his role as a global product manager at Vitrolife, he has been directly responsible for the majority of that company’s international new product launches.
Shareholdings in Emotra AB (including wife’s holdings): 1,290,976 shares.
Lars-Håkan Thorell is the inventor of “EDOR®”, Emotra’s measuring method and product system. Associate professor in experimental psychiatry with more than 40 years’ research experience. He has conducted research on suicide, psychophysiology and hyporeactivity for 25 years. For many of these years his place of employment has been the Institute for Clinical and Experimental Medicine, Psychiatry Department, at the Linköping University.
Married to Elizabeth Kaminski.
Shareholdings in Emotra AB: 0 shares.
Anna Sjörs Dahlman has a PhD in Rehabilitation Medicine from Linköping University. She has a background in Engineering Biology, with a specialization in non-invasive physiological measurements. The focus in Anna Sjörs Dahlman’s research has been on measuring the biological effects of short and long-term stress exposure, chronic pain, sleep deprivation, physical activity etc. Most of the research has been conducted at the Institute of Stress Medicine in Gothenburg, Sweden. She has been a guest researcher at Naval Postgraduate School in Monterey, CA, USA, and is also a board member of the Swedish Society of Behavioral Medicine.
Dr. Sjörs Dahlman has extensive experience in biomarker research, with an in-depth understanding of the EDOR-Test and has a position as a researcher at the Swedish national road and transport research institute.
Shareholdings in Emotra AB: 0 shares.
Jan Pilebjer, born in 1954, who basically holds an economics degree from Uppsala University, is Business Adviser and Business Intelligence Officer at GU Ventures AB. Pilebjer has worked in major worldwide companies and has founded and operated smaller start-up companies in both diagnostics and pharmaceuticals. Among Pilebjer’s international and industrial experiences are companies such as Baxter Healthcare Inc., Nycomed AS, KabiVitrum AB, Medirox AB, Biopool AB and Upjohn AB, where he held his base in countries such as Switzerland, the United States and Denmark.
Shareholdings in Emotra AB (including husband’s holdings): 1,290,976 shares.
Elizabeth Kaminski has specialist training in psychophysiological measurement and is one of Emotra AB’s founders. She has conducted her own research on psychophysiological reactions in children and adults and has performed hundreds of psychophysiological data measurements for employers such as Linköping University. Elizabeth is one of our processors of test data from Emotra’s customers and is a member of our evaluation team for new test versions.
Married to Lars-Håkan Thorell.
For cost-optimisation reasons, the Company has not yet employed a CFO. For this reason, Emotra AB’s accounting and financial reporting functions have been outsourced to Jonebrant Ekonomikonsult AB, Corp. id no: 556501-8115, Göteborgsvägen 74, SE-433 63 Sävedalen, Sweden.
Thomas Nilsson, Chartered Accountant at Ernst & Young AB, is the Company’s accountant, born 1962, Marcus Hellsten, at Ernst & Young AB is the Company’s substitute Accountant, born 1977 Address: Odinsgatan 13, SE-401 82 Göteborg, Sweden.